Anixa Biosciences Inc — Director's Dealing 2013

Sep 9, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2013-09-05

Reporting Person: HERMS HENRY P (Director, VP Finance and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-05	Common Stock	S	3850	$0.2175	Disposed	566725	Direct
2013-09-05	Common Stock	S	12500	$0.2125	Disposed	554225	Direct
2013-09-05	Common Stock	S	10000	$0.21	Disposed	544225	Direct
2013-09-05	Common Stock	S	9100	$0.205	Disposed	535125	Direct
2013-09-05	Common Stock	S	5000	$0.204	Disposed	530125	Direct
2013-09-05	Common Stock	S	9500	$0.2025	Disposed	520625	Direct
2013-09-06	Common Stock	S	5000	$0.21	Disposed	515625	Direct
2013-09-09	Common Stock	S	2500	$0.215	Disposed	513125	Direct
2013-09-09	Common Stock	S	7500	$0.2125	Disposed	505625	Direct
2013-09-09	Common Stock	S	27500	$0.21	Disposed	478125	Direct